Patent application number | Description | Published |
20120088755 | Novel Compounds - The present invention relates to the new compounds of general formula I | 04-12-2012 |
20120202829 | 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders - The invention relates to novel 6-Cycloalkyl-pyrazolopyrimidinones according to formula (I). | 08-09-2012 |
20130029949 | Substituted Quinolines and Their Use As Medicaments - Disclosed are substituted quinolines of formula 1 | 01-31-2013 |
20140073641 | 1-HETEROCYCLYL-1,5-DIHYDRO-PYRAZOLO[3,4-D] PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A MODULATORS - The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones, wherein i.) the nitrogen atom of the pyrazolo-group that is next to the pyrimidino-group is attached to a non-aromatic, organic heterocycle having at least one ring hetero atom selected from O, N and S and ii.) to the C-atom between the two nitrogen atoms of the pyrimidinone-ring a second substituent is bound via an optionally substituted methylene-bridge. According to one aspect of the invention the new compounds are for the manufacture of medicaments, in particular medicaments for the treatment of conditions concerning deficits in perception, concentration, learning or memory. The new compounds are also for the manufacture of medicaments for the treatment of Alzheimer's disease. | 03-13-2014 |
20140350025 | COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS - The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones of formula (I), | 11-27-2014 |
20150025088 | 6-CYCLOALKYL-PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF CNS DISORDERS - The invention relates to novel 6-Cycloalkyl-pyrazolopyrimidinones according to formula (I). | 01-22-2015 |
20150065489 | Substituted Quinolines and Their Use As Medicaments - Disclosed are substituted quinolines of formula 1 | 03-05-2015 |
20150126503 | SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS MEDICAMENTS - The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, | 05-07-2015 |